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AbsTrACT
The NHS ’Choose Wisely’ campaign places greater 
emphasis on the clinician-patient dialogue. Patients 
are often in receipt of their laboratory data and want 
to know whether they are normal. But what is meant 
by normal? Comparator data, to a measured value, 
are colloquially known as the ’normal range’. It is 
often assumed that a result outside this limit signals 
disease and a result within health. However, this range 
is correctly termed the ’reference interval’. The clinical 
risk from a measured value is continuous, not binary. 
The reference interval provides a point of reference 
against which to interpret an individual’s results—rather 
than defining normality itself. This article discusses the 
theory of normality—and describes that it is relative 
and situational. The concept of normality being not 
an absolute state influenced the development of the 
reference interval. We conclude with suggestions 
to optimise the use and interpretation of the 
reference interval, thereby facilitating greater patient 
understanding.
The ‘Choose Wisely’ campaign was introduced by 
the Academy of Medical Royal Colleges in 2016 
with a view to encouraging a dialogue between 
clinician and patient regarding the practice of 
evidence-based treatment regimens.1 Clinicians 
have access to a vast array of investigations and 
interpretation of the results of these tests is central 
to our role. A fundamental question that the patient 
wants answered is ‘are my tests normal?’
buT whAT is meAnT by ‘normAl’?
With every test result, the clinical laboratory will 
provide comparator value(s) to help the clinician 
place the result in context. The comparator values 
are often referred to as the normal range. A frequent 
occurrence is for the results within this interval to 
be colour coded, for instance black if the result is 
within the range and red when outside of it. This 
reinforces the concept of a result having a binary 
quality: normal or abnormal.
If we say that a blood result is normal, a number 
of inferences of dissimilar nature could be put 
on this. The difficulty was neatly captured by the 
philosopher Edmond Murphy in 1960s (table 1).2 
In the clinical setting, our experience is that the 
term is frequently used to imply that the patient 
has no physiological derangement and/or that the 
distribution follows a Gaussian distribution.
If it is assumed that a ‘normal’ result has no patho-
physiological derangement, the corollary would be 
that a result outside this limit would signal a disease 
state. This seems an arbitrary dichotomous inter-
pretation. As the American psychiatrist, Theodore 
Rubin, put it ‘health may be considered a relative 
and not an absolute state’. Health may be conceived 
differently in different countries, or in the same 
country at different times, or even in the same indi-
vidual at different ages.
How did the ‘normal range’ develop? First, some 
semantics; the reference limit is the upper and 
lower extreme of the reference interval, whereas 
the reference range refers to the difference between 
two values. If, for instance, we take the upper and 
lower reference limits for sodium as 135 and 145 
mmol/L, respectively, the range is 10 mmol/L while 
the interval is 135–145 mmol/L. An observed value 
is a value of a particular type obtained by measure-
ment (blood testing), produced to make a medical 
decision: this may then be compared with a refer-
ence limit or reference interval.
Until the 1960s, laboratories often worked in 
isolation and developed their own comparator 
values to define normal limits. It became apparent 
that multiple ‘normal ranges’ were required for 
different patient populations and for individual 
laboratories, to account for methodological vari-
ation. The clinical practice at the time was to 
compare a patient’s results with an ill-defined or at 
least inconsistently defined, range of values—called 
the ‘normal range’). This was derived from a popu-
lation of supposedly ‘normal’ (meaning healthy) 
individuals. The concept of the reference interval 
was then introduced by Grasbeck and Saris in 19693 
as it was felt that the concept of a normal range, as 
then conceived, was flawed. The reference interval 
was designed to describe fluctuations of blood 
analyte concentrations in well-characterised groups 
of individuals in order to replace the more ambig-
uous concept of normal values. The intention was 
to have a point of reference against which to inter-
pret an individual’s results—rather than defining 
normality itself. Normality is relative and situa-
tional. The population reference interval may not 
account for factors such as age, ethnicity or gender 
unless they have a major impact. Therefore, the 
reference interval is an approximation of what can 
be expected in the population. This difficulty has 
been recognised in critical care medicine leading to 
calls for the development of a new normative data 
base for the critically ill.4
Often what underpins both these methods is the 
assumption that using a Gaussian distribution, to 
identify the middle 95% of individuals, will identify 
healthy individuals. There are three criticisms of 
the use and terminology applied here; First, values 
may not fall into a bell-shaped distribution but can 
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Table 1 Interpretations of ‘normal’ (modified from Murphy, 19662)
Conceptions of normal suggested alternatives
1 Determined statistically Gaussian
2 Most representative of its class Average, median, modal
3 Most commonly encountered Habitual
4 Wild-type: most suited to survival & 
reproduction
Fittest
5 Harmless ‘carrying no penalty’ Innocuous/harmless
6 Most often aspired to Conventional
7 The most perfect of its class Ideal
Figure 1 Fasting triglyceride as an example of a skewed (non-
Gaussian) distribution.
Figure 2 Two Gaussian distributions with no overlap.
Figure 3 Overlapping Gaussian distributions.
be skewed. Fasting triglyceride is a good example of this. The 
most common triglyceride value (the mode) is not found at the 
midpoint of the population density curve but to one side—the 
distribution is skewed to the right (figure 1).
Second, no underlying theory assumes that the central 95% 
is physiologically normal. The 95% interval is based on prag-
matism—two SD from the mean was considered suitably distant 
from the mean and was taken from Fisher’s development of 
the hypothesis-testing technique of Neyman and Pearson.5 
However, there is no reason why the central 90% could not be 
used—although such an approach would increase false positives 
or the central 99%—although this would increase the rate of 
false negatives.
Third, the bell-shaped distribution that we term the ‘normal 
distribution’ is something of a misnomer. It was commonly 
referred to as ‘Gaussian’ until another mathematician, Karl 
Pearson, adopted the term ‘normal distribution’, referring to the 
fact that the distribution pattern was ubiquitous in life. The term 
was not introduced for its propensity to identify ‘normal’ indi-
viduals.6 For instance, a blood urea value at the upper end of the 
reference interval may represent significant renal impairment in 
an individual who has liver dysfunction and cannot adequately 
synthesise urea.
Just as a result within the reference interval may be ‘abnormal’, 
so might a result outside the interval be ‘normal’ (seen in the 
presence of health). For instance, mild hyponatraemia in the 
elderly may not necessarily represent disease. Physiological 
changes associated with ageing can include elevated antidiuretic 
hormone and atrial natriuretic hormone levels as well as an 
increased responsiveness to osmotic stimulation.7 It is extremely 
unusual in nature for the two distributions (of health and disease) 
to be separate and discrete (figure 2). Disease and health are not 
dichotomous but are dynamic, inter-related and the variables to 
define them usually overlap (figure 3).
Thus, it can be seen that a patient may be classed as healthy 
at an individual level but diseased at a population level and vice 
versa (figures 3 and 4).
The laboratory report seldom features one value in isola-
tion. Rather, a whole panel of tests are requested, analysed and 
reported, such as U&Es, LFTs, bone profile; cumulatively, these 
are sometimes referred to as a comprehensive metabolic panel. 
What are the chances that out of a panel of tests, one will be 
abnormal? We can use the binomial distribution to test this. 
In statistics, the binomial distribution has only two outcomes: 
‘success or failure’, ‘positive or negative’, ‘yes or no’. The 
binomial equation to determine the probability (p) of a single 
‘success’ when performing a sequence of n independent tests is:
 (1− p)n−1 
The chance of a positive blood test result (‘success’) is 0.05 
(because 5% of population values lie outside the normal distri-
bution and, as described above, in this instance are considered as 
abnormal). Therefore, the probability that one result is abnormal 
in a panel of 20 tests is:
 (1− 0.05)20−1 = 0.9519 = 0.38 
There is therefore a 38% chance that 1 of the 20 of the tests 
will be abnormal. This value is indicative only, as it assumes 
independence of the analytes being tested, whereas often they 
are related, for example, alkaline phosphatase may change in 
tandem with gamma-glutamyl transferase.
how can the reference limit support a decision? how can it 
discriminate?
We have described that the clinical risk from an observed value 
is continuous and so we must take care that the reference limit 
is not confused with a decision limit. This is a different way 
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Figure 4 Detection of an outlier.
Table 2 Features of a decision limit and a reference interval (modified from Ceriotti and Henny, 20089)
reference intervals Decision limits
Definition The interval between, and including, two reference limits, which are 
values derived from the distribution of the results obtained from a 
sample of the reference population.
The best dividing lines between the diseased and the not diseased 
or between ‘those who need not be investigated further’ and ‘those 
who do’.
Conditions influencing them  ► Population
 ► Age group
 ► Gender
 ► Clinical question
 ► Patient category
Information gathered Whether or not the patient is part of the reference population Whether or not the patient is eligible for a certain procedure 
(‘treatment’)
Statistics 95% central range of the distribution curve  ► None (consensus values)
 ► ROC curves
 ► Predictive values
Data number Two (lower and upper limits) One, without any CI
There can sometimes be >1, but according to the likelihood of 
various clinical situations or different clinical questions
ROC, receiver operating characteristic.
Figure 5 Interindividual variation greater than intraindividual 
variation.
of conveying information; an observed value is still presented 
but there is less ambiguity in how the clinician should respond 
at or beyond the decision limit. A decision limit is based on 
the sensitivity and specificity of a test at various threshold test 
settings. A good example of this is the glycated haemoglobin 
(HbA1c)—a value of 42 mmol/mol is considered ‘normal’ and 
48 mmol/mol is, with specific preanalytic criteria met, consis-
tent with a diagnosis of diabetes mellitus. If, instead of a deci-
sion limit to diagnose diabetes, a reference interval was used 
(where only the outlying 5% of the population are considered 
‘abnormal’), a large number of individuals who currently have 
the diagnosis of diabetes would be reclassified as ‘normal’. This 
is because, using a decision limit, the prevalence of diabetes in 
England is estimated at 9% of the adult population,8 whereas 
it would drop to 2.5% if HbA1c>2 SD from the mean (ie, the 
tail of a Gaussian distribution) were used instead to determine 
diabetes.
The differences between reference intervals and decision limits 
are summarised in table 2 (modified from Ceriotti et al9). Deci-
sion limits are appearing more frequently in laboratory reports. 
They have the advantage of making decisions more reproduc-
ible but reproducibility is not always helpful, especially if the 
benefits of a decision limit are applied to the wrong population. 
The ubiquity of decision limits may also entrench the idea of 
applying categorical outcomes to continuous data.
what could be done?
Language is important, as we see from table 1, normal means 
different things to different people, and to the same person in 
different circumstances. The phrase ‘normal range’ is unhelpful 
and inaccurate.
a. Question why the information is being gathered. Is it for 
benchmarking for the future; screening; completing a panel 
or performing a diagnostic investigation?
b. Will the investigation change the odds of something? 
Consider limiting indiscriminate testing.
c. Relate the observed value to preceding values whenever 
possible. The intraindividual variation in laboratory values 
is usually much smaller than the interindividual variability 
(ie, the variation in the population; figure 5). Variation in 
the concentration of an analyte, if significantly outside of a 
patient’s usual values (but still within the reference interval), 
could be a sign of early or latent disease.10 Thus, a haemoglo-
bin of 130 g/L in a male, though within the reference interval 
(130–180 g/L), might represent a fall from (unmeasured) 170 
g/L. The result must be interpreted in the light of the clinical 
history.
The graphical representation of preceding data (if available) can 
be extremely effective in identifying trends (figure 4). The atyp-
ical result for Patient A may be due to:
 ► Preanalytical error (how the sample was taken or trans-
ported to the laboratory).11
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Figure 6 Regression to the mean. On repetition, values furthest from 
the mean tend to have greater change than values starting close to the 
mean.
 ► Analytical error (how the sample was processed in the 
laboratory).
 ► Intraindividual fluctuations of the variable measured 
(unlikely given the pattern of variation up to that point).
 ► A real pathology. Attempts have been made to capture this 
from a ‘critical difference calculation’. The critical differ-
ence is defined as ‘the smallest difference between sequen-
tial laboratory results in a patient which is likely to indicate 
a true change in the patient’ and the calculation requires 
specifics of the laboratory (analytical) variation as well as 
within-subject biological variation.12
In this situation, assuming that no pretest probability had been 
estimated (ie, that the sample was not specifically requested to 
test a theory), the sample may be: (1) supplemented by historic 
data and further findings—as with the example above (enhance-
ment or lowering of probability that they form a component of 
disease).
(2) Repeated (reduces the chances being secondary to a prean-
alytic or analytic error or to intraindividual fluctuations). Repe-
tition, if chosen, should be made at intervals appropriate to the 
expected rate of development of possible disease. The observed 
value on repetition may well have shifted closer to the centre of 
the reference interval—a phenomenon known as ‘regression to 
the mean’.
regression to the mean
This is a statistical tendency where unusually large or small 
measurements tend to be followed by measurements that are 
closer to the mean13 (figure 6). The term was introduced by 
Francis Galton in the late 19th century as a consequence of 
his investigations of the relationship between the heights of 
parents and their children. The heights of children of very tall 
parents tended to be shorter (and vice versa) so that over time it 
‘regressed’ (or ‘reverted’) to the population mean. In medicine, 
this phenomenon can sometimes suggest an efficacy of a treat-
ment—that may in fact be having no effect at all.
ConClusion
The reference interval is an extremely useful means of contextu-
alising a patient’s result but it is wrong to automatically assume 
‘normality’ of a result within that interval, just as it is wrong to 
assume abnormality outside of the interval. Normality is relative 
and situational. With understanding of the nature of the refer-
ence interval, logical decisions can be made that will improve the 
effectiveness of the clinical consultation.
main messages
 ► Health is a relative and not an absolute state.
 ► The reference interval acts as a comparator for the patient’s 
blood result. It is not the arbiter of whether disease is present 
or not.
 ► Natural fluctuations in a blood result can occur.
 ► Comparison of a result against the reference interval should 
be informed by the clinical suspicion made beforehand.
Contributors MBW and PK contributed jointly to the manuscript.
Funding The authors have not declared a specific grant for this research from any 
funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4.0
RefeRences
 1 Wise J. Choosing Wisely: how the UK intends to reduce harmful medical overuse. BMJ 
2017;356:j370.
 2 Murphy EA. A scientific viewpoint on normalcy. Perspect Biol Med 1966;9:333–48.
 3 Gräsbeck R. The evolution of the reference value concept. Clin Chem Lab Med 
2004;42:692–7.
 4 Kilickaya O, Schmickl C, Ahmed A, et al. Customized reference ranges for laboratory 
values decrease false positive alerts in intensive care unit patients. PLoS One 
2014;9:e107930.
 5 Fisher R. Statistical methods for research workers. 5th edn. Edinburgh, UK: Oliver & 
Boyd, 1934.
 6 Wilcox RR. Understanding and applying basic statistical methods using R. Wiley, 
2016.
 7 Cowen LE, Hodak SP, Verbalis JG. Age-associated abnormalities of water homeostasis. 
Endocrinol Metab Clin North Am 2013;42:349–70.
 8 Diabetes prevalence estimates for local populations. Secondary Diabetes prevalence 
estimates for local populations. 2015. Available from: https://www. gov. uk/ 
government/ publications/ diabetes- prevalence- estimates- for- local- populations
 9 Ceriotti F, Henny J. "Are my Laboratory Results Normal?" Considerations to be Made 
Concerning Reference Intervals and Decision Limits. EJIFCC 2008;19:106–14.
 10 Harris EK. Effects of intra- and interindividual variation on the appropriate use of 
normal ranges. Clin Chem 1974;20:1535–42.
 11 Whyte MB, Vincent RP. How the routine reporting of laboratory measurement 
uncertainty might affect clinical decision making in acute and emergency medicine. 
Emerg Med J 2016;33:278–9.
 12 Jones GR. Critical difference calculations revised: inclusion of variation in standard 
deviation with analyte concentration. Ann Clin Biochem 2009;46(Pt 6):517–9.
 13 Bland JM, Altman DG. Regression towards the mean. BMJ 1994;308:1499.
 o
n
 16 April 2019 by guest. Protected by copyright.
http://pmj.bmj.com/
Postgrad M
ed J: first published as 10.1136/postgradm
edj-2018-135983 on 13 November 2018. Downloaded from 
